{"id":"W2461531801","doi":"10.1200/jco.2012.30.27_suppl.104","title":"Safety of everolimus for women over age 65 with advanced breast cancer (BC): 12.5-month follow-up of BOLERO-2.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Medicine; Everolimus; Exemestane; Internal medicine; Adverse effect; Tolerability; Breast cancer; Rash; Placebo; Population; Aromatase inhibitor; Oncology; Cancer; Aromatase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003119979,0.0005608264,0.001514743,0.0006417775,0.0005051509,0.0007517024,0.0004551586,0.001343361,0.002629117],"category_scores_gemma":[0.002577344,0.0003232833,0.002314348,0.0005621387,0.0003197122,0.0009821333,0.0005353647,0.001551428,0.0008523055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004840108,"about_ca_system_score_gemma":0.0004075747,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001041192,"about_ca_topic_score_gemma":0.001705976,"domain_scores_codex":[0.9993424,0.0002232529,0.00006378661,0.0001208618,0.0001253151,0.000124448],"domain_scores_gemma":[0.9977487,0.0003093159,0.001041229,0.0001938402,0.0002307837,0.0004761742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5848505,0.006505723,0.2753671,0.0007628524,0.00405342,0.0005493223,0.0003177344,0.001026008,0.005458514,0.00007728194,0.003444201,0.1175873],"study_design_scores_gemma":[0.02415511,0.09956381,0.8633836,0.0001393678,0.004563591,0.0006049712,0.0001132034,0.0008033927,0.001923172,0.0001446659,0.004540249,0.00006488868],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828328,0.01033647,0.000313864,0.0003996812,0.00008582235,0.0003517922,0.003028263,0.00005915253,0.002592156],"genre_scores_gemma":[0.991771,0.001257909,0.0002707727,0.0006224918,0.0001175804,0.000225408,0.004113737,0.0000101414,0.001610842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003119979,"threshold_uncertainty_score":0.01650017,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05807774968586379,"score_gpt":0.4320381526482892,"score_spread":0.3739604029624254,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}